Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Haefliger

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
The Journal of Antimicrobial Chemotherapy|January 17, 2025
Individualization of piperacillin dosage based on therapeutic drug monitoring with or without model-informed precision dosing: a scenario analysisDavid Haefliger, Lynn Mina, Monia Guidi, et al.
Clinical Pharmacokinetics|November 25, 2025
Population Pharmacokinetics of Levosimendan and its Metabolites OR-1855 and OR-1896 in Critically Ill Adults, Neonates and Infants on Veno-Arterial ECMOStéphane Bertin, Monia Guidi, David Haefliger, et al.
Clinical Pharmacology and Therapeutics|June 24, 2026
Ruxolitinib Pharmacokinetics and Exposure-Toxicity Relationship in Hematologic Malignancies and Immune-Mediated Diseases: A Prospective Observational StudyJérémie Tachet, Sara C Meyer, Francesco Grandoni, et al.
Journal of Pharmaceutical and Biomedical Analysis|December 25, 2024
Highly sensitive ultra-high-performance liquid chromatography coupled with tandem mass spectrometry method for the multiplex analysis of levosimendan and its metabolites OR-1855 and OR-1896 in human plasmaStéphane Bertin, François Versace, Thomas Mercier, et al.
Journal of Clinical Pharmacology|May 30, 2024
Novel Patient-Friendly Orodispersible Formulation of Ivermectin is Associated With Enhanced Palatability, Controlled Absorption, and Less Variability: High Potential for Pediatric UseKim Dao, Michael Buettcher, Klervi Golhen, et al.
Plos One|November 13, 2020
Epidemiology, risk factors and clinical course of SARS-CoV-2 infected patients in a Swiss university hospital: An observational retrospective studyJean Regina, Matthaios Papadimitriou-Olivgeris, Raphaël Burger, et al.
BMJ Open|April 25, 2024
Use of GLP1 receptor agonists in early pregnancy and reproductive safety: a multicentre, observational, prospective cohort study based on the databases of six Teratology Information ServicesKim Dao, Svetlana Shechtman, Corinna Weber-Schoendorfer, et al.
Journal of General Internal Medicine|March 23, 2022
Post‑COVID‑19 Syndrome in Outpatients: a Cohort StudyFlorian Desgranges, Eliana Tadini, Aline Munting, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
The Journal of Antimicrobial Chemotherapy|January 17, 2025
Individualization of piperacillin dosage based on therapeutic drug monitoring with or without model-informed precision dosing: a scenario analysisDavid Haefliger, Lynn Mina, Monia Guidi, et al.
Clinical Pharmacokinetics|November 25, 2025
Population Pharmacokinetics of Levosimendan and its Metabolites OR-1855 and OR-1896 in Critically Ill Adults, Neonates and Infants on Veno-Arterial ECMOStéphane Bertin, Monia Guidi, David Haefliger, et al.
Clinical Pharmacology and Therapeutics|June 24, 2026
Ruxolitinib Pharmacokinetics and Exposure-Toxicity Relationship in Hematologic Malignancies and Immune-Mediated Diseases: A Prospective Observational StudyJérémie Tachet, Sara C Meyer, Francesco Grandoni, et al.
Journal of Pharmaceutical and Biomedical Analysis|December 25, 2024
Highly sensitive ultra-high-performance liquid chromatography coupled with tandem mass spectrometry method for the multiplex analysis of levosimendan and its metabolites OR-1855 and OR-1896 in human plasmaStéphane Bertin, François Versace, Thomas Mercier, et al.
Journal of Clinical Pharmacology|May 30, 2024
Novel Patient-Friendly Orodispersible Formulation of Ivermectin is Associated With Enhanced Palatability, Controlled Absorption, and Less Variability: High Potential for Pediatric UseKim Dao, Michael Buettcher, Klervi Golhen, et al.
Plos One|November 13, 2020
Epidemiology, risk factors and clinical course of SARS-CoV-2 infected patients in a Swiss university hospital: An observational retrospective studyJean Regina, Matthaios Papadimitriou-Olivgeris, Raphaël Burger, et al.
BMJ Open|April 25, 2024
Use of GLP1 receptor agonists in early pregnancy and reproductive safety: a multicentre, observational, prospective cohort study based on the databases of six Teratology Information ServicesKim Dao, Svetlana Shechtman, Corinna Weber-Schoendorfer, et al.
Journal of General Internal Medicine|March 23, 2022
Post‑COVID‑19 Syndrome in Outpatients: a Cohort StudyFlorian Desgranges, Eliana Tadini, Aline Munting, et al.
Pageof 2